WINT Rega marang bathi mangsa ngarep Windtree Therapeutics

Windtree Therapeutics (WINT) is developing a closed-loop peptide system for the treatment of cardiogenic shock. The company's forward P/E ratio displayed on GURU.Markets visualizes this process, where the parameter value equals 0.00. Robotic blood biochemistry analysis optimizes clinical tests, while management, operating under strict resource austerity, focuses on identifying strategic partners for business development.

WINT - Rasio rega marang bathi mangsa ngarep Windtree Therapeutics, Inc. ing rentang 04.07.2022 - 06.09.2025

Rincian metrik keuangan lan pasar Windtree (WINT)

- kuotasi lan prakiraan analis:

Rega saham Windtree Therapeutics|WINT - Target median analis

- data kapitalisasi pasar:

Nilai pasar Windtree Therapeutics Inc.|WINT - Nilai Bisnis

- data ekuitas miturut neraca:

Nilai Buku saben Saham Windtree Therapeutics|WINT - Kapitalisasi Akuntansi|Rasio Kapitalisasi marang Aset Bersih windtreetx.com|WINT - Aset Agregat Bisnis

- rincian struktur utang lan likuiditas bisnis:

Utang marang Ekuitas Windtree Therapeutics|WINT - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Windtree Therapeutics|WINT - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Windtree Therapeutics Inc.|WINT - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Windtree Therapeutics|Indikator likuiditas cepet windtreetx.com

- statistik bathi lan rasio pasar:

WINT - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep Windtree Therapeutics|WINT - Nilai perusahaan marang bathi resik|Pangali Forward P/E Windtree Therapeutics|WINT - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Windtree Therapeutics Inc.|WINT - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Windtree Therapeutics|WINT - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan windtreetx.com|WINT - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Windtree Therapeutics

Analisis kabeh metrik perusahaan:Windtree Therapeutics, Inc.

Windtree Therapeutics (WINT) resilience to volatility is driven by exclusive patents in cardiogenic shock therapy and stringent FDA oversight, rendering future revenues dependent on regulatory milestones. Analyzing the company's expected P/E ratio at 0.00, an investor assesses the current share price through the lens of projected earnings to determine the asset's degree of overheating and the risk of a prolonged capital freeze.

Pesaing Windtree Therapeutics (WINT)

Pangali Forward P/E REGN|Kapitalisasi marang proyeksi bathi iRhythm Technologies, Inc.|Rega marang bathi mangsa ngarep Lantheus Medical Imaging LNTH|MLYS: Rasio rega marang bathi mangsa ngarep|HeartFlow, Inc. - Pangali Forward P/E|KMTS (kestramedical.com) - Rasio rega marang bathi mangsa ngarep|ESPR (Esperion) - Prakiraan rega marang bathi|AMRN: Rasio kapitalisasi marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Anteris|TNYA: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E CVRX|MIST - Rasio prakiraan rega marang bathi|Pangali Forward P/E CRDL (Cardiol Therapeutics Inc.)|HeartBeam Inc (BEAT) - Rasio prakiraan rega marang bathi|TENX: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ADGM (Adagio Medical, Inc.)|BCDA (BioCardia, Inc.) - Prakiraan rega marang bathi|VTAK: Rasio kapitalisasi marang bathi mangsa ngarep|ABIO (ARCA Biopharma Inc) - Pangali Forward P/E|ACST: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E AVTE|VERV - Rasio prakiraan rega marang bathi